Publication:
Persistent de Quervain tenosynovitis induced by somatotropin treatment

Simple item page
dc.contributor.authorYurdakul, OZAN VOLKAN
dc.contributor.authorAyture, Ltfiye
dc.contributor.authorYALCINKAYA, Ebru Yilmaz
dc.contributor.institutionauthorYURDAKUL, OZAN VOLKAN
dc.date.accessioned2020-10-29T20:27:11Z
dc.date.available2020-10-29T20:27:11Z
dc.date.issued2017-11-01T00:00:00Z
dc.description.abstractBackground: Growth hormone deficiency is a well-known clinical entity that is usually treated with somatotropin (growth hormone). Growth hormone has some frequent side effects such as intracranial hypertension, lymphedema and diabetes mellitus.
dc.identifier.citationYurdakul O. V. , Ayture L., YALCINKAYA E. Y. , -Persistent de Quervain tenosynovitis induced by somatotropin treatment-, JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.30, ss.1223-1226, 2017
dc.identifier.doi10.1515/jpem-2017-0085
dc.identifier.scopus85033235485
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26051
dc.identifier.wosWOS:000414040800013
dc.titlePersistent de Quervain tenosynovitis induced by somatotropin treatment
dc.typeArticle
dspace.entity.typePublication
local.avesis.id6a6d1662-43e3-4f33-bba3-a219e2d98107
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicationc1e20611-abc7-4e87-9f05-90fc101835ff
relation.isAuthorOfPublication.latestForDiscoveryc1e20611-abc7-4e87-9f05-90fc101835ff
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler